X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study
- PMID: 14514738
- DOI: 10.1097/01.asn.0000090034.71205.74
X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study
Abstract
Alport syndrome (AS) is a type IV collagen hereditary disease characterized by progressive hematuric nephritis, hearing loss, and ocular changes. Mutations in the COL4A5 collagen gene are responsible for the more common X-linked dominant form of the disease characterized by much less severe disease in girls and women. A "European Community Alport Syndrome Concerted Action" (ECASCA) group was established to delineate the Alport syndrome phenotype in each gender and to determine genotype-phenotype correlations in a large number of families. Data concerning 329 families, 250 of them with an X-linked transmission, were collected. Characteristics of heterozygous girls and women belonging to the 195 families with proven COL4A5 mutation are compared with those of hemizygous boys and men. Hematuria was observed in 95% of carriers and consistently absent in the others. Proteinuria, hearing loss, and ocular defects developed in 75%, 28%, and 15%, respectively. The probability of developing end-stage renal disease or deafness before the age of 40 yr was 12% and 10%, respectively, in girls and women versus 90 and 80%, respectively, in boys and men. The risk of progression to end-stage renal disease appears to increase after the age of 60 yr in women. Because of the absence of genotype-phenotype correlation and the large intrafamilial phenotypic heterogeneity, early prognosis of the disease in X-linked Alport syndrome carriers remains moot. Risk factors for developing renal failure have been identified: the occurrence and progressive increase in proteinuria, and the development of a hearing defect.
Similar articles
-
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.J Am Soc Nephrol. 2000 Apr;11(4):649-657. doi: 10.1681/ASN.V114649. J Am Soc Nephrol. 2000. PMID: 10752524
-
Alport syndrome. Molecular genetic aspects.Dan Med Bull. 2009 Aug;56(3):105-52. Dan Med Bull. 2009. PMID: 19728970
-
Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1441-1449. doi: 10.2215/CJN.01000116. Epub 2016 Jun 8. Clin J Am Soc Nephrol. 2016. PMID: 27281700 Free PMC article.
-
Familial hematuria: A review.Medicina (Kaunas). 2017;53(1):1-10. doi: 10.1016/j.medici.2017.01.002. Epub 2017 Jan 31. Medicina (Kaunas). 2017. PMID: 28236514 Review.
-
[From Alport syndrome to benign familial hematuria: clinical and genetic aspect].Nephrol Ther. 2005 May;1(2):90-100. doi: 10.1016/j.nephro.2005.03.005. Epub 2005 Jun 1. Nephrol Ther. 2005. PMID: 16895672 Review. French.
Cited by
-
The multifaceted links between hearing loss and chronic kidney disease.Nat Rev Nephrol. 2024 May;20(5):295-312. doi: 10.1038/s41581-024-00808-2. Epub 2024 Jan 29. Nat Rev Nephrol. 2024. PMID: 38287134 Review.
-
X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome.Nephrol Dial Transplant. 2010 Mar;25(3):764-9. doi: 10.1093/ndt/gfp551. Epub 2009 Oct 23. Nephrol Dial Transplant. 2010. PMID: 19854849 Free PMC article.
-
Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation.Int J Nephrol Renovasc Dis. 2018 Oct 16;11:267-270. doi: 10.2147/IJNRD.S150539. eCollection 2018. Int J Nephrol Renovasc Dis. 2018. PMID: 30410383 Free PMC article. Review.
-
Incidentally Diagnosed Alport Syndrome in a Patient with Drug-Induced Vasculitis.Case Rep Nephrol. 2019 Apr 10;2019:8720837. doi: 10.1155/2019/8720837. eCollection 2019. Case Rep Nephrol. 2019. PMID: 31093390 Free PMC article.
-
Renal impairment in Alport syndrome pregnant woman: Case report and review of the literature.Clin Case Rep. 2020 Sep 15;8(12):3003-3007. doi: 10.1002/ccr3.3328. eCollection 2020 Dec. Clin Case Rep. 2020. PMID: 33363868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials